Taken together, these results indicate that annexin A2 depletion resulted in a loss of cellular redox regulatory capability, which became critical as these cancer cells were subjected to enhanced oxidative stress in the tumour site in vivo. The gene discussed is ANXA2; the disease is neoplasm.